Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2021 | 2020
Number of items: 2.

2021

Moehler, M., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J., Motoyama, S., Lievre, A., Uronis, H., Elimova, E., Grootscholten, C., Geboes, K., Zhang, J., Soleymani, S., Lei, M., Kondo, K., Cleary, J. and Kelly, R. J. (2021). Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577. Ann. Oncol., 32. S. S1045 - 3. AMSTERDAM: ELSEVIER. ISSN 1569-8041

2020

Kelly, R. J., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J. L., Motoyama, S., Lievre, A., Uronis, H., Elimova, E., Grootscholten, C., Geboes, K., Zhang, J., Zhu, L., Lei, M., Kondo, K., Cleary, J. M. and Moehler, M. (2020). Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study. Ann. Oncol., 31. S. S1193 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

This list was generated on Thu Mar 28 21:36:26 2024 CET.